Managing Myeloma website offers scholarship for attending the December 2009 American Society of Hematology Annual Meeting

NewsGuard 100/100 Score

Managing Myeloma (www.ManagingMyeloma.com), an accredited multi-supported educational website for multidisciplinary professionals, announces the opportunity for fellows in oncology to win a scholarship to attend the December 2009 American Society of Hematology Annual Meeting in New Orleans, Louisiana. The scholarship includes registration fees, airfare, hotel accommodations, and a per diem for meals.

During the conference, the scholarship winners will participate in an information gathering and reporting activity based on identified poster and oral sessions relevant to multiple myeloma. The articles generated will be published on the Managing Myeloma website.

"The Managing Myeloma Scholarship Program is a great opportunity for fellows to learn more about multiple myeloma, meet colleagues, hold discussions with leading myeloma experts and have their summaries of poster and oral sessions from the conference published to benefit the community of practicing physicians, pharmacists, and nurses not in attendance at this prestigious scientific meeting," said Sheri Sturgis, chief operating officer of MediCom Worldwide, the accredited developer of the Managing Myeloma site.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel dual-target CAR T cell therapy shows promise in treating recurrent glioblastoma